By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > VMAT2 inhibitors > Tetrabenazine > Tetrabenazine Dosage
VMAT2 inhibitors
https://themeditary.com/dosage-information/tetrabenazine-dosage-6955.html

Tetrabenazine Dosage

Drug Detail:Tetrabenazine (Tetrabenazine (tet ra ben' a zeen))

Drug Class: VMAT2 inhibitors

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Usual Adult Dose for Huntington Disease

  • Initial Dose: 12.5 mg orally per day once in the morning; increase to 12.5 mg orally twice a day after one week.
  • Maintenance Dose: Titrate up slowly at weekly intervals by 12.5 mg daily.
  • Maximum Single Dose: 25 mg

Comments:
  • Administer doses 37.5 mg/day or greater in a 3 times a day regimen.
  • Determine CYP450 2D6 metabolizer status in patients who require doses of greater than 50 mg per day.

Use: Chorea associated with Huntington's disease.

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Use is contraindicated.

Dose Adjustments

CYP450 Poor Metabolizers:

  • Maximum Single Dose: 25 mg
  • Maximum Daily Dose: 50 mg

CYP450 Extensive and Intermediate Metabolizers:
  • Maximum Single Dose: 37.5 mg
  • Maximum Daily Dose: 100 mg

Concomitant Use with Strong CYP450 2D6 Inhibitors:
  • Maximum Single Dose: 25 mg
  • Maximum Daily Dose: 50 mg

Occurrence of Adverse Reaction (e.g., akathisia, restlessness, parkinsonism, depression, insomnia, anxiety, sedation): Reduce the dose and consider discontinuing this drug or initiating other treatment (e.g., antidepressants) if events do not resolve.

Treatment Interruption:
  • Less than 5 days: Resume treatment at the previous maintenance dose without titration.
  • Greater than 5 days: Re-titrate with therapy resumption.

Precautions

US BOXED WARNING:

  • This drug can increase the risk of depression and suicidality; close observation for the emergence or worsening of depression, suicidality, or unusual behavior changes should accompany therapy.
  • Patients, their families, and caregivers should be informed of the risk and instructed to report concerning behaviors promptly to their healthcare providers.
  • Particular caution should be exercised in treating any patient with a history of depression or prior suicide attempts or ideation.
  • This drug is contraindicated in patients who are actively suicidal or with untreated or inadequately treated depression.

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available.

Other Comments

Administration Advice:

  • Individualize dosage for each patient.
  • Take this drug without regard to food.
  • May discontinue this drug without tapering.

Storage Requirements:
  • Protect from light.

General:
  • It is unlikely this drug will be of benefit if there is no improvement after 7 to 10 days at the maximum dose.

Monitoring:
  • Signs and symptoms of akathisia, agitation, restlessness, new or worsening depression, suicidality

Patient Advice:
  • Avoid alcohol and other sedating drugs during treatment.

Frequently asked questions

  • How long does it take for Xenazine (tetrabenazine) to work?
  • What's the difference between deutetrabenazine and tetrabenazine?
  • What's the mechanism of action for Xenazine (tetrabenazine)?
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by